According to a new market report published by Lucintel, the future of the healthcare specialty enzyme market looks promising with opportunities in various applications, such as pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts. The global healthcare specialty enzyme market is expected to grow with a CAGR of 7% from 2020 to 2025. The major drivers for this market are rising demand for non-harmful biological catalysts in pharmaceuticals & diagnostics, increasing prevalence of metabolic diseases, and growing adoption of preventive medicines.
To download report brochure, please go to https://www.lucintel.com/healthcare-specialty-enzyme-market.aspx and click "download brochure" tab from the menu
Specialty enzymes are proteins that act as biocatalysts for accelerating various types of chemical reactions without undergoing self-changes. In this market, carbohydrases, proteases, lipases, and polymerases & nucleases are the major types. Lucintel forecasts that polymerases & nucleases will remain the largest type segment over the forecast period due to increasing research activities and rising application of enzymes in the pharmaceutical industry.
Within this market, pharmaceuticals will remain the largest application segment over the forecast period due to increasing prevalance of metabolic diseases.
North America will remain the largest region over the forecast period due to favorable government regulations, technological advancments, and presence of major pharmaceutical companies in the region.
Novozymes, Codexis, Affymetrix, Advanced Enzymes Technologies, Biocatalysts, BBI Solutions, Sekisui Diagnostics, Roche, Amano Enzymes, and Amicogen are among the major suppliers in the global healthcare specialty enzyme market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global healthcare specialty enzyme market by type, source, form, application, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Healthcare Specialty Enzyme Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global healthcare specialty enzyme market by type, source, form, application, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Carbohydrases
Proteases
Lipases
Polymerases & Nucleases
Other Enzymes
By Source [Value ($ Million) shipment analysis for 2014 – 2025]:
Microorganisms
Plants
Animals
By Form [Value ($ Million) shipment analysis for 2014 – 2025]:
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceuticals
Research & Biotechnology
Diagnostics
Biocatalysts
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.